Walleye Trading
ARKG icon

Walleye Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History

Walleye Trading’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.22M Buy
147,900
+90,000
+155% +$2.87M 0.01% 1178
2026
Q1 		$1.53M Buy
57,900
+20,700
+56% +$606K ﹤0.01% 1867
2025
Q4 		$1.08M Sell
37,200
-16,100
-30% -$483K ﹤0.01% 2325
2025
Q3 		$1.48M Sell
53,300
-25,100
-32% -$634K ﹤0.01% 2006
2025
Q2 		$1.91M Buy
78,400
+18,000
+30% +$394K ﹤0.01% 1751
2025
Q1 		$1.25M Buy
60,400
+2,400
+4% +$60.3K ﹤0.01% 1924
2024
Q4 		$1.37M Sell
58,000
-4,300
-7% -$106K ﹤0.01% 1935
2024
Q3 		$1.59M Sell
62,300
-3,500
-5% -$89.1K ﹤0.01% 1820
2024
Q2 		$1.54M Buy
65,800
+15,100
+30% +$381K ﹤0.01% 1769
2024
Q1 		$1.46M Sell
50,700
-36,800
-42% -$1.11M ﹤0.01% 1943
2023
Q4 		$2.87M Sell
87,500
-300
-0.3% -$8.16K 0.01% 1637
2023
Q3 		$2.45M Sell
87,800
-9,600
-10% -$314K 0.01% 1636
2023
Q2 		$3.32M Sell
97,400
-12,800
-12% -$402K 0.01% 1273
2023
Q1 		$3.31M Sell
110,200
-34,400
-24% -$1.07M 0.01% 1346
2022
Q4 		$4.08M Buy
144,600
+36,900
+34% +$1.17M 0.01% 1197
2022
Q3 		$3.54M Buy
107,700
+11,900
+12% +$437K 0.01% 1272
2022
Q2 		$3.02M Buy
95,800
+17,600
+23% +$615K 0.01% 1353
2022
Q1 		$3.59M Buy
+78,200
New +$3.73M 0.01% 1216
2021
Q4 		– Sell
-6,400
Closed -$478K – 5314
2021
Q3 		$478K Sell
6,400
-14,700
-70% -$1.23M ﹤0.01% 2962
2021
Q2 		$1.95M Buy
21,100
+17,200
+441% +$1.46M 0.01% 1520
2021
Q1 		$346K Buy
+3,900
New +$387K ﹤0.01% 3076

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Walleye Trading's ARKG Position: Q2 2026 in Review

Walleye Trading sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 70,990 shares — an estimated $2.26M sold.

Walleye Trading first reported a position in ARKG in Q3 2021 and held it in 8 quarters. The position peaked at $4M in Q4 2023. 274 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Walleye Trading reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 70,990 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $2.26M.
  • Walleye Trading first reported a position in ARK Genomic Revolution ETF in Q3 2021 and held it in 8 quarters.
  • Walleye Trading's ARK Genomic Revolution ETF position peaked at $4M in Q4 2023.
  • 274 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.